APA (7th ed.) Citation

S, O., O, K., U, O., D, I., H, S., S, A., . . . N, T. (2026). Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma. Journal of cancer research and clinical oncology, 152(1), 33. https://doi.org/10.1007/s00432-025-06411-7

Chicago Style (17th ed.) Citation

S, Oksuz, et al. "Association Between GRIm Score and Response to Nivolumab Monotherapy in Patients with Advanced Malignant Melanoma." Journal of Cancer Research and Clinical Oncology 152, no. 1 (2026): 33. https://doi.org/10.1007/s00432-025-06411-7.

MLA (9th ed.) Citation

S, Oksuz, et al. "Association Between GRIm Score and Response to Nivolumab Monotherapy in Patients with Advanced Malignant Melanoma." Journal of Cancer Research and Clinical Oncology, vol. 152, no. 1, 2026, p. 33, https://doi.org/10.1007/s00432-025-06411-7.